Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.21
+0.07 (0.98%)
At close: Jun 27, 2025, 4:00 PM
7.36
+0.15 (2.08%)
After-hours: Jun 27, 2025, 4:30 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $44.42 million as of June 27, 2025. Its market cap has increased by 5.34% in one year.
Market Cap
44.42M
Enterprise Value
-85.55M
1-Year Change
5.34%
Ranking
Category
Stock Price
$7.21
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $44.42M, a decrease of -91.97%. That is a compound annual growth rate of -41.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 43.66M | -70.47% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |